Amifampridine

Amifampridine (3,4-diaminopyridine) is a potassium channel blocker used in the treatment of Lambert-Eaton myasthenic syndrome (LEMS). It enhances acetylcholine release at the neuromuscular junction. Mediocon Inc supplies pharmaceutical-grade Amifampridine for rare disease and specialty neurological manufacturers.

Key Features

• Potassium channel blocker for LEMS
• EP compliant quality
• Enhances neuromuscular transmission
• Approved for rare neuromuscular disease

Applications

• Lambert-Eaton myasthenic syndrome tablets
• Neuromuscular disease management
• Rare disease specialty formulations
• Congenital myasthenic syndrome

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings